• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈癌和外阴癌患者的癌胚抗原。血清水平与疾病进展。

Carcinoembryoinc antigen in cervical and vulvar cancer patients. Serum levels and disease progress.

作者信息

DiSaia P J, Morrow C P, Haverback B J, Dyce B J

出版信息

Obstet Gynecol. 1976 Jan;47(1):95-9.

PMID:1246404
Abstract

Serial carcinoembryonic antigen (CEA) assays were performed on 10 patients with primary invasive squamous cell carcinoma of the cervix, 7 patients with recurrent squamous cell carcinoma of the cervix, and 5 patients with invasive squamous carcinoma of the vulva. Plasma CEA determinations were accomplished by radioimmunoassay, using a modification of Hanson's method. In 8 of the 10 patients with invasive squamous cell carcinoma of the cervix, positive CEA values dropped to normal ranges during the course of radiotherapy, usually in the first 4 weeks of treatment. A similar decrease in patients' serum values was seen after surgical extirpation of recurrent squamous cell carcinoma of the cervix by pelvic exenteration. Serum values also dropped to within normal limits in a limited number of patients with squamous cell carcinoma of the vulva after complete removal of all gross disease. Persistence of disease was associated with all gross disease. Persistence of disease was associated with chronically elevated values. A suggestion is made that patients with elevated CEA values may be followed with serial determinations to substantiate complete eradication of their disease.

摘要

对10例原发性宫颈浸润性鳞状细胞癌患者、7例复发性宫颈鳞状细胞癌患者和5例外阴浸润性鳞状细胞癌患者进行了癌胚抗原(CEA)系列检测。血浆CEA测定采用放射免疫分析法,对汉森方法进行了改进。10例宫颈浸润性鳞状细胞癌患者中有8例,其CEA阳性值在放疗过程中,通常在治疗的前4周降至正常范围。通过盆腔脏器清除术手术切除复发性宫颈鳞状细胞癌后,患者血清值也出现了类似下降。在完全切除所有肉眼可见病变后,少数外阴鳞状细胞癌患者的血清值也降至正常范围内。疾病持续存在与所有肉眼可见病变相关。疾病持续存在与CEA值长期升高相关。有人建议,对于CEA值升高的患者,可通过系列检测进行随访,以证实其疾病已被彻底根除。

相似文献

1
Carcinoembryoinc antigen in cervical and vulvar cancer patients. Serum levels and disease progress.宫颈癌和外阴癌患者的癌胚抗原。血清水平与疾病进展。
Obstet Gynecol. 1976 Jan;47(1):95-9.
2
Prognostic significance of pretreatment squamous cell carcinoma antigen and carcinoembryonic antigen in squamous cell carcinoma of the uterine cervix.治疗前鳞状细胞癌抗原和癌胚抗原在子宫颈鳞状细胞癌中的预后意义。
Gynecol Oncol. 1997 Mar;64(3):418-24. doi: 10.1006/gyno.1996.4589.
3
Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay.
Obstet Gynecol. 1989 Dec;74(6):944-9.
4
[Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].[鳞状细胞癌抗原对复发性子宫颈鳞状细胞癌患者的影响]
Zhonghua Fu Chan Ke Za Zhi. 2008 Jan;43(1):13-7.
5
Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.子宫颈腺癌患者的肿瘤标志物CA 125、鳞状细胞癌抗原和癌胚抗原。
Obstet Gynecol. 1989 Apr;73(4):661-8.
6
[CEA and the clinical course in advanced carcinoma of the uterine cervix (author's transl)].[癌胚抗原与晚期宫颈癌的临床病程(作者译)]
Geburtshilfe Frauenheilkd. 1982 Jun;42(6):462-7. doi: 10.1055/s-2008-1036797.
7
[Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].[血清鳞状细胞癌抗原与子宫颈鳞状细胞癌临床病理特征及预后的相关性]
Zhonghua Fu Chan Ke Za Zhi. 2007 Jan;42(1):29-33.
8
[Significance of determination of squamous cell carcinoma antigen in the follow up of patients with cancer of the uterine cervix].[鳞状细胞癌抗原测定在子宫颈癌患者随访中的意义]
Orv Hetil. 1992 Dec 13;133(50):3191-4.
9
[Carcino-embryonic antigen in cases of cervical carcinoma (author's transl)].
Zentralbl Gynakol. 1981;103(21):1273-9.
10
Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.肿瘤标志物癌胚抗原(CEA)、组织多肽抗原(TPA)和鳞状细胞癌抗原(SCC-Ag)在国际妇产科联盟(FIGO)低风险IB期和IIA期子宫颈鳞状细胞癌患者中的应用。
Gynecol Oncol. 2000 Jan;76(1):103-6. doi: 10.1006/gyno.1999.5665.